Voogd C E, Schot C S, van Leeuwen W J, van Klingeren B
National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.
Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):164-7. doi: 10.1007/BF01967070.
During surveillance of antimicrobial resistance in Shigella strains isolated in the Netherlands from 1984 to 1989 and forwarded to the National Institute of Public Health and Environmental Protection for typing, sensitivity to twelve antimicrobial agents was assessed. High rates of resistance to the older drugs of choice in treating shigellosis were found, i.e. ampicillin and trimethoprim-sulfamethoxazole. Ampicillin resistance varied from 33 to 53% among Shigella flexneri strains and from 10 to 17% among Shigella sonnei strains. Trimethoprim and trimethoprim-sulfamethoxazole resistance increased from 8% to about 25% among Shigella flexneri and from 16 to 46% among Shigella sonnei isolates. All strains were susceptible to the newer quinolones, but five strains resistant to nalidixic acid showed decreased susceptibility to norfloxacin. Approximately 10% of the isolates were resistant to the combination of ampicillin, trimethoprim and sulfamethoxazole.
在对1984年至1989年荷兰分离的志贺氏菌菌株进行抗菌药物耐药性监测并将其送交国家公共卫生和环境保护研究所进行分型时,评估了这些菌株对12种抗菌药物的敏感性。结果发现,对治疗志贺氏菌病的传统首选药物,即氨苄青霉素和甲氧苄啶 - 磺胺甲恶唑的耐药率很高。在弗氏志贺氏菌菌株中,氨苄青霉素耐药率在33%至53%之间,在宋内志贺氏菌菌株中为10%至17%。在弗氏志贺氏菌中,甲氧苄啶和甲氧苄啶 - 磺胺甲恶唑耐药率从8%增至约25%,在宋内志贺氏菌分离株中从16%增至46%。所有菌株对新型喹诺酮类药物敏感,但5株对萘啶酸耐药的菌株对诺氟沙星的敏感性降低。约10%的分离株对氨苄青霉素、甲氧苄啶和磺胺甲恶唑的联合用药耐药。